Eagle Ridge Investment Management - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 153 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eagle Ridge Investment Management ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$807,000
-46.7%
94,875
-22.6%
0.21%
-69.5%
Q2 2015$1,515,000
+8.5%
122,500
+4.3%
0.68%
+7.7%
Q1 2015$1,396,000
+33.6%
117,500
+27.0%
0.63%
+32.6%
Q4 2014$1,045,000
+44.3%
92,500
+12.1%
0.48%
+37.0%
Q3 2014$724,000
+20.5%
82,5000.0%0.35%
+24.2%
Q2 2014$601,000
+495.0%
82,500
+312.5%
0.28%
+473.5%
Q1 2014$101,00020,0000.05%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q1 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders